“Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S9. doi:10.25251/skin.3.supp.9.